Biotech Values

[Biowatch]

thestreet.com admits they were wrong on New River

http://www.thestreet.com/_yahoo/funds/investing/10339799.html

A Missed Boat on New River

By Marc Lichtenfeld
Senior Columnist
2/20/2007 1:54 PM EST

When you pick stocks for a living, whether it's as a portfolio manager, trader, analyst or columnist, you're bound to end up with both winners and losers over time. Every so often, a stock will end up burned in your memory as an example of perfect execution or everything going wrong.

With the buyout Tuesday of New River Pharmaceuticals (NRPH - Cramer's Take - Stockpickr - Rating) by Shire (SHPGY - Cramer's Take - Stockpickr - Rating), the New River story will leave me shaking my head in bewilderment for years to come, wondering where my analysis went wrong.

etc.